English
Sun Pharmaceutical Industries Q4 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,805.00
-13.60 (-0.75%)
-13.60 (-0.75%)Volume36.39 K
Updated: Fri 5 Dec, 2025 | 15:29:51
NSE
1,805.30-13.00 (-0.71%)
-13.00 (-0.71%)Volume1.78 M
Updated: Fri 5 Dec, 2025 | 15:54:21
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Sun Pharmaceutical Industries Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 10,559.46 | 10,429.82 | 1.24% | 9,585.09 | 10.17% |
| Depreciation/ Amortization | 663.79 | 630.56 | 5.27% | 650.36 | 2.07% |
| Operating Income | 2,399.38 | 3,245.64 | -26.07% | 2,397.81 | 0.07% |
| Net Income | 2,149.88 | 2,903.38 | -25.95% | 2,654.58 | -19.01% |
| Other Operating Expenses Total | 4,408.28 | 4,190.27 | 5.20% | 4,093.41 | 7.69% |
| Net Income Before Taxes | 3,254.35 | 3,476.40 | -6.39% | 2,815.52 | 15.59% |
| Total Revenue | 12,958.84 | 13,675.46 | -5.24% | 11,982.90 | 8.14% |
| Selling/ General/ Admin Expenses Total | 2,488.52 | 2,552.28 | -2.50% | 2,360.72 | 5.41% |
| Diluted Normalized EPS | 9.95 | 13.21 | -24.63% | 11.56 | -13.88% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.